Chalasani N - Search Results

1

Idiosyncratic drug-induced liver injury: a clinical update.

Maddur H, Chalasani N. Maddur H, et al. Among authors: chalasani n. Curr Gastroenterol Rep. 2011 Feb;13(1):65-71. doi: 10.1007/s11894-010-0154-8. Curr Gastroenterol Rep. 2011. PMID: 21049293 Review.

2

Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity.

Chalasani N, Aljadhey H, Kesterson J, Murray MD, Hall SD. Chalasani N, et al. Gastroenterology. 2004 May;126(5):1287-92. doi: 10.1053/j.gastro.2004.02.015. Gastroenterology. 2004. PMID: 15131789

3

Severe liver injury after initiating therapy with atomoxetine in two children.

Lim JR, Faught PR, Chalasani NP, Molleston JP. Lim JR, et al. J Pediatr. 2006 Jun;148(6):831-4. doi: 10.1016/j.jpeds.2006.01.035. J Pediatr. 2006. PMID: 16769398

4

Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?

Vuppalanchi R, Liangpunsakul S, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. Am J Gastroenterol. 2007 Mar;102(3):558-62; quiz 693. doi: 10.1111/j.1572-0241.2006.01019.x. Am J Gastroenterol. 2007. PMID: 17156142

5

Lipid-lowering agents that cause drug-induced hepatotoxicity.

Bhardwaj SS, Chalasani N. Bhardwaj SS, et al. Among authors: chalasani n. Clin Liver Dis. 2007 Aug;11(3):597-613, vii. doi: 10.1016/j.cld.2007.06.010. Clin Liver Dis. 2007. PMID: 17723922 Free PMC article. Review.

6

Nonalcoholic fatty liver disease as a component of the metabolic syndrome.

Khashab MA, Liangpunsakul S, Chalasani N. Khashab MA, et al. Among authors: chalasani n. Curr Gastroenterol Rep. 2008 Feb;10(1):73-80. doi: 10.1007/s11894-008-0012-0. Curr Gastroenterol Rep. 2008. PMID: 18417046 Review.

7

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J; Drug Induced Liver Injury Network (DILIN). Chalasani N, et al. Gastroenterology. 2008 Dec;135(6):1924-34, 1934.e1-4. doi: 10.1053/j.gastro.2008.09.011. Epub 2008 Sep 17. Gastroenterology. 2008. PMID: 18955056 Free PMC article.

8

Nonalcoholic fatty liver disease and cardiovascular risk.

Misra VL, Khashab M, Chalasani N. Misra VL, et al. Among authors: chalasani n. Curr Gastroenterol Rep. 2009 Feb;11(1):50-5. doi: 10.1007/s11894-009-0008-4. Curr Gastroenterol Rep. 2009. PMID: 19166659 Free PMC article.

9

Drug-induced liver injury in clinical trials: as rare as hens' teeth.

Davern TJ, Chalasani N. Davern TJ, et al. Among authors: chalasani n. Am J Gastroenterol. 2009 May;104(5):1159-61. doi: 10.1038/ajg.2009.76. Epub 2009 Apr 7. Am J Gastroenterol. 2009. PMID: 19352346 Review.

10

Epidemiology of idiosyncratic drug-induced liver injury.

Bell LN, Chalasani N. Bell LN, et al. Among authors: chalasani n. Semin Liver Dis. 2009 Nov;29(4):337-47. doi: 10.1055/s-0029-1240002. Epub 2009 Oct 13. Semin Liver Dis. 2009. PMID: 19826967 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

583 results

Search Page

Filters